These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1364068)

  • 1. Mucosal plasminogen activator activity in peptic ulcer disease.
    Wodzinski MA; Bardhan KD; Cooper P; Reilly JT; Preston FE
    Ann N Y Acad Sci; 1992 Dec; 667():181-2. PubMed ID: 1364068
    [No Abstract]   [Full Text] [Related]  

  • 2. [The histoenzymological and ultrastructural changes in the gastric mucosa in peptic ulcer after treatment with pirenzepine and histamine H2-receptor blockaders].
    Degtiareva II; Kharchenko NV; Lodianaia EV; Zukheĭr Kh; Tokar' DV; Nevstruev VP; Piletskiĭ AM
    Lik Sprava; 1995; (1-2):48-51. PubMed ID: 7483543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced tissue type plasminogen activator activity of the gastroduodenal mucosa in peptic ulcer disease.
    Wodziński MA; Bardhan KD; Reilly JT; Cooper P; Preston FE
    Gut; 1993 Oct; 34(10):1310-4. PubMed ID: 8244093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of ulcer healing--a new concept to rank healed peptic ulcers.
    Arakawa T; Kobayashi K
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():158-62. PubMed ID: 8103020
    [No Abstract]   [Full Text] [Related]  

  • 5. [Histamine H2 receptor antagonists. Notes on clinical pharmacology].
    Pelosio L; Marasco A; Naim U
    Clin Ter; 1979 Nov; 91(4):421-7. PubMed ID: 44237
    [No Abstract]   [Full Text] [Related]  

  • 6. [Gastric acid secretion inhibitors: H2 receptor antagonists (H2RA), proton pump inhibitors (PPI) or acid pump antagonists (APA)].
    Mazure PA
    Acta Gastroenterol Latinoam; 1996; 26(4):263-5. PubMed ID: 9335935
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment and prevention of nonsteroidal anti-inflammatory drug induced gastrointestinal mucosal injury.
    Agrawal NM; Dajani EZ
    Int J Clin Pharmacol Res; 1989; 9(6):347-57. PubMed ID: 2576801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological inhibition of gastric secretion and treatment of peptic ulcer].
    Konturek SJ
    Rev Esp Enferm Apar Dig; 1978 Apr; 53(1):65-82. PubMed ID: 26940
    [No Abstract]   [Full Text] [Related]  

  • 9. [Non-proteolytic enzymes of human gastric and duodenal mucosa in peptic ulcer].
    Ivanov GG
    Vopr Med Khim; 1976; 22(3):339-42. PubMed ID: 1030892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the isoenzymatic aspect of the digestive mucosa. Experimental and clinical study].
    Chiriloiu C; Zamfirescu-Gheorghiu M; Matei M
    Stud Cercet Med Interna; 1971; 12(1):61-5. PubMed ID: 5565780
    [No Abstract]   [Full Text] [Related]  

  • 11. [Perspectives in the drug therapy of peptic ulcer].
    Kamada T; Sato N; Kawano S
    Nihon Rinsho; 1988 Jan; 46(1):7-11. PubMed ID: 2897487
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antirheumatic drug-induced damage of the gastroduodenal mucosa: approach to prevention].
    Domschke S; Domschke W
    Internist (Berl); 1986 Oct; 27(10):630-6. PubMed ID: 2878905
    [No Abstract]   [Full Text] [Related]  

  • 13. Adenylate cyclase of human gastric mucosa. Stimulation of enzyme activity by histamine and catecholamines.
    Simon B; Kather H
    Digestion; 1977; 16(1-2):175-9. PubMed ID: 28260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Distribution and properties of the alkaline phosphatase in the human gastric mucosa in peptic ulcer].
    Ivanov GG
    Vopr Med Khim; 1978; 24(2):206-10. PubMed ID: 664446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal mucosal gamma-glutamyl transpeptidase activity changes in different ulcer models of rat.
    Náfrádi J; Balint GA; Csáti S; Varró V
    Agents Actions; 1984 Dec; 15(5-6):549-50. PubMed ID: 6152378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New class of pharmacological preparations: histamine H2-receptors blockaders (a review of the literature)].
    Ionov ID
    Farmakol Toksikol; 1978; 41(5):624-32. PubMed ID: 81139
    [No Abstract]   [Full Text] [Related]  

  • 17. Histamine H2-receptor antagonists in peptic ulcer disease. Evidence for a prophylactic use.
    Nash J; Lambert L; Deakin M
    Drugs; 1994 Jun; 47(6):862-71. PubMed ID: 7521828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosa protectives: sucralfate and colloidal bismuth subcitrate in peptic ulcer disease.
    Tytgat GN; Nio CY
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():152-61. PubMed ID: 3660894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histamine and its role in peptic gastric diseases: the discovery of histamine-H2-receptor antagonists].
    Barth H; Lorenz W
    Acta Med Austriaca; 1978; 5(2):25-31. PubMed ID: 32719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NSAID-induced peptic ulcer disease: a critical review of pathogenesis and management.
    Scheiman JM
    Dig Dis; 1994; 12(4):210-22. PubMed ID: 7851000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.